时钟基因PER 在肿瘤中的研究进展 |
| |
引用本文: | 杨金昊(综述),王平(审校). 时钟基因PER 在肿瘤中的研究进展[J]. 中国肿瘤临床, 2016, 43(10): 446-450. DOI: 10.3969/j.issn.1000-8179.2016.10.352 |
| |
作者姓名: | 杨金昊(综述) 王平(审校) |
| |
作者单位: | 作者单位:①天津医科大学(天津市300070);②天津医科大学肿瘤医院放射治疗科,国家肿瘤临床医学研究中心,天津市肿瘤防治重点实验室 |
| |
摘 要: | 昼夜节律钟控制着人类及大多数哺乳动物每天的体温、血压、激素、代谢等节律,这是由于昼夜节律基因调控的结果。PER(period)基因是核心昼夜节律基因之一,现已确认人类的PER 基因包括PER 1、PER 2 和PER 3,均是抑癌基因。PER 基因的表达异常不仅能促进肿瘤的发生,还能改变细胞对放射线和化疗药物的敏感性,为肿瘤患者的放疗和化疗提供新的治疗方向。本文在将对昼夜节律钟基因PER 在肿瘤中的研究进展进行综述。
|
关 键 词: | 昼夜节律钟 PER 基因? 抑癌? 放射治疗? 化学治疗 |
收稿时间: | 2016-03-27 |
Research progress on the circadian clock gene PER in tumors |
| |
Affiliation: | 1Tianjin Medical University, Tianjin 300070, China; |
| |
Abstract: | Circadian clock governs 24-hour rhythms in body temperature, blood pressure, circulating hormones, metabolism, and oth-er physiological parameters in humans and most mammals. The circadian clock is regulated by circadian clock genes. For instance, peri-od (PER) is a core circadian clock gene. Human PER includes PER1, PER2, and PER3, which play a role in cancer suppression. Abnormal PER expression not only causes cancer but also changes cellular sensitivity to radiation and chemotherapeutic drugs. Thus, this theory has provided a new direction for cancer radiotherapy and chemotherapy. This paper presents the research progress on PER in tumors. |
| |
Keywords: | circadian clock PER gene cancer suppressor radiotherapy chemotherapy |
本文献已被 万方数据 等数据库收录! |
| 点击此处可从《中国肿瘤临床》浏览原始摘要信息 |
|
点击此处可从《中国肿瘤临床》下载免费的PDF全文 |
|